UNSPSC 51284007: Etamocycline

This classification denotes a tetracycline antibiotic with the molecular formula C50H60N6O16, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 96D1L38S9Q chemically known as n,n,-(ethylenebis((methylimino)methylene))bis-(4'-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide) but generally known as etamocycline, which bears US NIH Compound Identifier 5464330.

UNSPSC 51284007 Etamocycline is a Commodity code that does not align with the state and local procurement opportunities recently tagged under it. The four posted solicitations—covering naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, medical and first aid supplies for fire rescue, and generic pharmaceuticals through cooperative purchasing—bear no relationship to etamocycline, a tetracycline antibiotic with limited contemporary clinical use. The mismatch suggests either a data-entry error in the source tagging or that etamocycline itself sees negligible state and local procurement activity. State and local health agencies, fire departments, and cooperative purchasing alliances are actively buying naloxone, emergency medical supplies, and generic pharmaceuticals through RFPs, RFQs, and ITBs, but etamocycline does not appear in any of these recent solicitations.

No representative recent opportunities for etamocycline procurement are present in the source. The code shows little relevant activity and warrants skipping unless your firm has a specific manufacturer relationship or prior intelligence that a jurisdiction intends to stock the drug. Monitor cooperative purchasing alliances such as MMCAP and state health agencies for generic pharmaceutical RFPs if you hold an etamocycline supply agreement, but do not expect the current opportunity pipeline under this code to produce near-term prospects.